A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache
NCT ID: NCT01946126
Last Updated: 2016-03-15
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
459 participants
OBSERVATIONAL
2014-03-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine
NCT02037425
Cabergoline as a Preventive Treatment for Chronic Migraine
NCT05525611
CGRP-induced Migraine Attacks in Patients Who Have Tried Anti-CGRP Monoclonal Antibody Treatment
NCT03481400
Evaluating the Effectiveness of a Headache Management Program in Primary Care Settings
NCT05067725
Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine
NCT06412965
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic Migraine Diagnosis
This is a retrospective chart review for patients diagnosed with Chronic Migraine. There is no intervention in this study.
No Intervention
There is no intervention in this study.
Other Headache Diagnoses
This is a retrospective chart review of patients with headache diagnoses other than Chronic Migraine. There is no intervention in this study.
No Intervention
There is no intervention in this study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention
There is no intervention in this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eight (8) headache days per month for at least 1 of the preceding 15 months
Exclusion Criteria
* History of receiving botulinum toxin injections for the treatment of chronic migraine.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Director
Role: STUDY_DIRECTOR
Allergan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Raleigh, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GMA-BTX-CM-13-592
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.